Janet Dillione, Director at CorMedix Inc. (CRMD), bought 52,083 shares at $0.48 ($25K) on 2017-12-12, disclosed to the SEC on 2017-12-14.
Open-market purchase of $25k CRMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CRMD | SELL | 2025-12-04 | $467K | — | Filing → |
| CRMD | SELL | 2025-11-26 | $523K | — | Filing → |
| CRMD | SELL | 2025-11-18 | $343K | — | Filing → |